Abstract
Purpose
The aim of this retrospective study was to estimate risk organ doses and to estimate radiation risks during the imaging work-up and treatment for aneurysmal subarachnoid hemorrhage (SAH).
Methods
The imaging procedures comprised computed tomography and digital subtraction angiography studies for diagnosis or endovascular interventional procedures in 50 consecutive patients. Equivalent organ doses (HT) to skin, brain, eye lens, salivary glands, thyroid and oral mucosa were measured using thermoluminescence dosimeters in an anthropomorphic head phantom. Picture archiving and communication system (PACS) and radiological information system (RIS) records were analyzed and the frequency of each imaging procedure was recorded as well as the registered individual kerma-length product (PKL) and the kerma-area product (PKA). The doses were computed by multiplying the recorded PKL and PKA values by the conversion coefficients HT/PKL and HT/PKA from the head phantom.
Results
The mean fluoroscopy time, PKL and PKA were 38 min, 7269 mGy cm and 286 Gy cm2, respectively. The estimated mean equivalent doses were as follows: skin 2.51 Sv, brain 0.92 Sv, eye lens 0.43 Sv and salivary glands 0.23 Sv. Maximum organ doses were 2.3–3.5 times higher than the mean. Interventional procedures contributed 66 % to skin dose, 55 % to brain dose and 25 % to eye lens dose. Of the patients with an estimated skin dose exceeding 6 Sv, only 1 developed temporary epilation.
Conclusion
The risk for radiation-induced cancer for SAH patients is low (2–3 cases per 1,000 patients, of which 90 % are expected to be benign types) compared with the risk of tissue reactions on the head such as skin erythema and epilation (1 temporary epilation per 50 patients).
Similar content being viewed by others
References
Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.
ICRP publication 85: avoidance of radiation injuries from medical interventional procedures. Ann. ICRP. 2000;30:2 (ISSN 0146-6453).
Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–84.
Imanishi Y, Fukui A, Niimi H, Itoh D, Nozaki K, Nakaji S, et al. Radiation-induced temporary hair loss as a radiation damage only occurring in patients who had the combination of MDCT and DSA. Eur Radiol. 2005;15:41–6.
ICRP. Statement on tissue reactions. Approved by the Commission on April 21, 2011, ICRP ref. 4825-3093-1464.http://www.icrp.org/docs/ICRP%20Statement%20on%20Tissue%20Reactions.pdf. Accessed 11 April 2012.
Gelfand AA, Josephson SA. Substantial radiation exposure for patients with subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2011;20:131–3.
Mamourian AC, Young H, Stiefel MF. Cumulative radiation dose in patients admitted with subarachnoid hemorrhage: a prospective study using a self-developing film badge. AJNR Am J Neuroradiol. 2010;31:1787–90.
Moskowitz SI, Davros WJ, Kelly ME, Fiorella D, Rasmussen PA, Masaryk TJ. Cumulative radiation dose during hospitalization for aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2010;31:1377–82.
Hillman J, Sturnegk P, Yonas H, Heron J, Sandborg M, Gunnarsson T, et al. Bedside monitoring of CBF with xenon-CT and a mobile scanner: a novel method in neurointensive care. Br J Neurosurg. 2005;19:395–401.
Sturnegk P, Mellergård P, Yonas H, Theodorsson A, Hillman J. Potential use of quantitative bedside CBF monitoring (Xe-CT) for decision making in neurosurgical intensive care. Br J Neurosurg. 2007;21:332–9.
Rossitti S. Endovascular coiling of intracranial aneurysms using bioactive coils: a single-center study. Acta Radiol. 2007;48:565–76.
Rossitti S, Pfister M. 3D road-mapping in endovascular treatment of cerebral aneurysms and arteriovenous malformations. Interv Neuroradiol. 2009;15:283–90.
Jestaedt L, Pham M, Bartsch AJ, Kunze E, Roosen K, Solymosi L, et al. Efficacy of balloon angioplasty in the treatment of vasospasm after aneurysmal SAH. Clin Neuroradiol. 2007;17:180–6.
ATOM 2002. Adult female phantom handling instructions. CIRS tissue simulating technology, 2428 Almeda Ave, Suite 212, Norfolk, Virginia 23513 USA. http://www.cirsinc.com, admin@cirsinc.com. Accessed 11 April 2012.
Sandborg M, Rossitti S, Pettersson H. Local skin and eye lens equivalent doses in interventional neuroradiology. Eur Radiol. 2010;20:725–33.
Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.
Raymond J, Guilbert F, Weill A, Georganos SA, Juravsky L, Lambert A, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke. 2003;34:1398–1403.
Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480–4.
Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst. 2002;94:1555–63.
Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958–1987. Radiat Res. 1994;137:S17–S67 [Erratum in: Radiat Res. 1994;139:129].
ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. Publication 103. Ann. ICRP. 2007;37:2–4.
Kemerink GJ, Frantzen MJ, Oei K, Sluzewski M, van Rooij WJ, Wilmink J, et al. Patient and occupational dose in neurointerventional procedures. Neuroradiology. 2002;44:522–8.
Cohnen M, Wittsack HJ, Assadi S, Muskalla K, Ringelstein A, Poll LW, et al. Radiation exposure of patient in comprehensive computed tomography of the head in acute stroke. AJNR Am J Neuroradiol. 2006;27:1741–5.
Suzuki S, Furui S, Matsumaru Y, Nobuyuki S, Ebara M, Abe T, et al. Patient skin dose during neuroembolization by multiple-point measurement using a radiosensitive indicator. AJNR Am J Neuroradiol. 2008;29:1076–81.
Mamourian A, O’Shea M, Maidment ADA. Cumulative radiation dose in patients with aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 2010;31:E87–E88 [Letter].
ICRP publication 60: Recommendations of the ICRP. Ann ICRP. 1991;21;1–3.
Magrassi L, Bongetta D, D’Ercole L, Lisciandro F, Arienta C, Thyrion FZ. Neuroembolization may expose patients to radiation doses previously linked to tumor induction. Acta Neurochir. 2012;154:33–41.
Gunnarsson T, Hillman J. Clinical usefulness of bedside intracranial morphological monitoring: mobile computerized tomography in the neurosurgery intensive care unit. Neurosurg Focus. 2000;9(5):E5.
Acknowledgements
The authors thank Magnus Gårdestig and Gudrun Alm Carlsson for calibrating the TLD and for giving valuable comments on the manuscript, respectively. Miriam Rodriguez Catarino, MD, PhD, performed some of the endovascular procedures. This work was supported by the regional ALF-research fund in Sweden.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sandborg, M., Nilsson Althén, J., Pettersson, H. et al. Patient Organ Radiation Doses During Treatment for Aneurysmal Subarachnoid Hemorrhage. Clin Neuroradiol 22, 315–325 (2012). https://doi.org/10.1007/s00062-012-0147-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-012-0147-0